IRIS Accounts Production v24.2.0.383 07029546 Board of Directors 1.4.23 31.3.24 31.3.24 3.9.24 0 0 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070295462023-03-31070295462024-03-31070295462023-04-012024-03-31070295462022-03-31070295462022-04-012023-03-31070295462023-03-3107029546ns15:EnglandWales2023-04-012024-03-3107029546ns14:PoundSterling2023-04-012024-03-3107029546ns10:Director12023-04-012024-03-3107029546ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3107029546ns10:SmallEntities2023-04-012024-03-3107029546ns10:Audited2023-04-012024-03-3107029546ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3107029546ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3107029546ns10:FullAccounts2023-04-012024-03-3107029546ns10:Director22023-04-012024-03-3107029546ns10:RegisteredOffice2023-04-012024-03-3107029546ns5:CurrentFinancialInstruments2024-03-3107029546ns5:CurrentFinancialInstruments2023-03-3107029546ns5:ShareCapital2024-03-3107029546ns5:ShareCapital2023-03-3107029546ns5:RetainedEarningsAccumulatedLosses2024-03-3107029546ns5:RetainedEarningsAccumulatedLosses2023-03-3107029546ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107029546ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3107029546ns5:CurrentFinancialInstruments2023-04-012024-03-31
REGISTERED NUMBER: 07029546 (England and Wales)









Financial Statements

for the Year Ended 31 March 2024

for

JP Medical Ltd

JP Medical Ltd (Registered number: 07029546)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


JP Medical Ltd

Company Information
for the Year Ended 31 March 2024







DIRECTORS: J P Vij
A Vij





REGISTERED OFFICE: 28 Church Road
Stanmore
Middlesex
HA7 4XR





REGISTERED NUMBER: 07029546 (England and Wales)





AUDITORS: Parker Cavendish
Chartered Accountants
Statutory Auditors
28 Church Road
Stanmore
Middlesex
HA7 4XR

JP Medical Ltd (Registered number: 07029546)

Statement of Financial Position
31 March 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Debtors 4 19,926 20,144
Cash at bank and in hand 98,231 108,121
118,157 128,265
CREDITORS
Amounts falling due within one year 5 (47,015 ) (58,602 )
NET CURRENT ASSETS 71,142 69,663
TOTAL ASSETS LESS CURRENT
LIABILITIES

71,142

69,663

CAPITAL AND RESERVES
Called up share capital 2,125,490 2,125,490
Retained earnings (2,054,348 ) (2,055,827 )
SHAREHOLDERS' FUNDS 71,142 69,663

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 September 2024 and were signed on its behalf by:





A Vij - Director


JP Medical Ltd (Registered number: 07029546)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

JP Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The company continues to have minimal expenditure and the directors have concluded that the company has sufficient resources available to continue trading for the next twelve months. The directors will continue to take steps to maintain continuity of the business. Accordingly, they consider it appropriate to continue to adopt the going concern basis in preparing these financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 18,179 18,179
Other debtors 1,747 1,965
19,926 20,144

Trade debtors include an amount due from the parent company.

JP Medical Ltd (Registered number: 07029546)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 5,836 6,302
Other creditors 41,179 52,300
47,015 58,602

Other creditors include an amount due to parent company which is unsecured, interest free and repayable on demand.

6. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Rashmin Shah (Senior Statutory Auditor)
for and on behalf of Parker Cavendish

7. RELATED PARTY DISCLOSURES

The company has taken advantage of the exemption in Financial Reporting Standard 102 from the requirement to disclose related party transactions with wholly owned subsidiaries within the group.

8. FRC ETHICAL STANDARD - PROVISIONS AVAILABLE FOR SMALL ENTITIES

In common with many other businesses of our size and nature we use our auditors to prepare and submit returns to the tax authorities and assist with the preparation of the financial statements.

9. ULTIMATE PARENT COMPANY

The company is a wholly owned subsidiary undertaking of Jaypee Brothers Medical Publishers Pvt. Ltd, a company incorporated in India. The registered office and business address of the parent undertaking is 4841/ A, Plot No. 22, H. No. 24, Second Floor, Ansari Road, Daryaganj, Delhi, India.

The smallest group in which the results of the company are consolidated is Jaypee Brothers Medical Publishers Pvt. Ltd.